Hualan Biological Vaccine Inc. (SHE:301207)

Hualan Biological Vaccine Statistics

Total Valuation

SHE:301207 has a market cap or net worth of CNY 9.35 billion. The enterprise value is 6.43 billion.

Market Cap	9.35B
Enterprise Value	6.43B

Important Dates

The last earnings date was Saturday, March 29, 2025.

Earnings Date	Mar 29, 2025
Ex-Dividend Date	Jun 14, 2024

Share Statistics

SHE:301207 has 595.00 million shares outstanding. The number of shares has decreased by -0.72% in one year.

Current Share Class	n/a
Shares Outstanding	595.00M
Shares Change (YoY)	-0.72%
Shares Change (QoQ)	-0.20%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	3.07%
Float	79.54M

Valuation Ratios

The trailing PE ratio is 45.75 and the forward PE ratio is 14.69.

PE Ratio	45.75
Forward PE	14.69
PS Ratio	8.29
PB Ratio	1.56
P/TBV Ratio	1.56
P/FCF Ratio	22.46
P/OCF Ratio	19.98
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 27.35, with an EV/FCF ratio of 15.43.

EV / Earnings	31.27
EV / Sales	5.70
EV / EBITDA	27.35
EV / EBIT	67.91
EV / FCF	15.43

Financial Position

The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.05.

Current Ratio	3.40
Quick Ratio	3.19
Debt / Equity	0.05
Debt / EBITDA	1.28
Debt / FCF	0.72
Interest Coverage	15.51

Financial Efficiency

Return on equity (ROE) is 3.35% and return on invested capital (ROIC) is 0.92%.

Return on Equity (ROE)	3.35%
Return on Assets (ROA)	0.76%
Return on Invested Capital (ROIC)	0.92%
Return on Capital Employed (ROCE)	1.56%
Revenue Per Employee	1.51M
Profits Per Employee	274,753
Employee Count	748
Asset Turnover	0.15
Inventory Turnover	1.50

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -31.93% in the last 52 weeks. The beta is 0.79, so SHE:301207's price volatility has been lower than the market average.

Beta (5Y)	0.79
52-Week Price Change	-31.93%
50-Day Moving Average	17.16
200-Day Moving Average	17.89
Relative Strength Index (RSI)	39.99
Average Volume (20 Days)	2,873,199

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SHE:301207 had revenue of CNY 1.13 billion and earned 205.52 million in profits. Earnings per share was 0.34.

Revenue	1.13B
Gross Profit	841.03M
Operating Income	94.64M
Pretax Income	214.55M
Net Income	205.52M
EBITDA	235.00M
EBIT	94.64M
Earnings Per Share (EPS)	0.34

Balance Sheet

The company has 3.23 billion in cash and 300.18 million in debt, giving a net cash position of 2.93 billion or 4.92 per share.

Cash & Cash Equivalents	3.23B
Total Debt	300.18M
Net Cash	2.93B
Net Cash Per Share	4.92
Equity (Book Value)	6.01B
Book Value Per Share	10.11
Working Capital	3.51B

Cash Flow

In the last 12 months, operating cash flow was 468.04 million and capital expenditures -51.60 million, giving a free cash flow of 416.45 million.

Operating Cash Flow	468.04M
Capital Expenditures	-51.60M
Free Cash Flow	416.45M
FCF Per Share	0.70

Margins

Gross margin is 74.57%, with operating and profit margins of 8.39% and 18.22%.

Gross Margin	74.57%
Operating Margin	8.39%
Pretax Margin	19.02%
Profit Margin	18.22%
EBITDA Margin	20.84%
EBIT Margin	8.39%
FCF Margin	36.93%

Dividends & Yields

This stock pays an annual dividend of 0.20, which amounts to a dividend yield of 1.28%.

Dividend Per Share	0.20
Dividend Yield	1.28%
Dividend Growth (YoY)	100.00%
Years of Dividend Growth	3
Payout Ratio	162.67%
Buyback Yield	0.72%
Shareholder Yield	1.99%
Earnings Yield	2.20%
FCF Yield	4.45%

Stock Splits

The last stock split was on June 7, 2023. It was a forward split with a ratio of 1.5.

Last Split Date	Jun 7, 2023
Split Type	Forward
Split Ratio	1.5

Scores

SHE:301207 has an Altman Z-Score of 6.07.

Altman Z-Score	6.07
Piotroski F-Score	n/a